|
The Center for Genetic Research Ethics
and Law (CGREAL) is one of four interdisciplinary Centers for
Excellence in Ethical, Legal and Social Implications Research
funded by the National Human
Genome Research Institute (NHGRI) of the National Institutes of
Health (NIH) to address some of the most pressing ethical, legal
and social questions raised by recent advances in genetic and
genomic research.
This center studies the ethical issues
in the design and conduct of human genetic research, including the protection of human subjects in research.
The center
conducts research, surveys
existing ethical, legal and social implications research and current
genetic research regulations and guidelines to determine how adequately
they address present and emerging ethical concerns, and develops resources that will contribute
to stronger policies and guidelines in genetic research.
This project is supported by NIH grant
#P50HG03390.
|
HIG HLIGHTS
This Week in CGREAL
Erica Haimes has been invited to join the UK's Human Fertilisation and Embryology Authority's Ethics and Law Advisory Committee and the International Society of Stem Cell Research (ISSCR) Ethics and Public Policy Committee, in order to provide insight into social science research on, and the social aspects of, assisted conception.
Congratulations to Patty Marshall, Aaron Goldenberg, and Christian Simon, who were among the recipients of the the widely sought NIH "Challenge Grants"!
Patty Marshall and Aaron Goldenberg's grant, "Community Voices On Health Disparities And Translational Genomics Research", will examine beliefs and experiences that influence understanding of genomic research and its application to health disparities among underserved and minority populations in Cleveland, Ohio, to identify barriers to genomics research relevant to health disparities, and to develop innovative approaches for addressing these barriers through collaborative community-based partnerships.
Christian Simon's challenge grant, "Managing Incidental Findings In The Genomic Era", will examine how the prospect of incidental findings is addressed in the context of GWAS and CMA, and continues to build on earlier work he did through a CGREAL seed grant.
Jeff Botkin has been appointed by Francis Collins as the Chair of the NIH Stem Cell Eligibility Working Group, which will vet human stem cell lines for NIH funded research, and Dena Davis will be a member of that committee!
|
